Moore Catherine, Cottrell Simon, Hoffmann Jörg, Carr Michael, Evans Hannah, Dunford Linda, Lawson Heather, Brown Kevin E, Jones Rachel
Molecular Diagnostics Unit, Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff CF14 4XW, United Kingdom.
Public Health Wales, Temple of Peace and Health, Cathays Park, Cardiff CF10 3NW, United Kingdom.
J Clin Virol. 2015 Jun;67:1-7. doi: 10.1016/j.jcv.2015.03.012. Epub 2015 Mar 17.
We describe the laboratory response to a large measles outbreak that occurred during 2012-2013 centred in mid and west Wales, UK.
To demonstrate the impact of rapid measles testing on the management of a large outbreak, to show the complex molecular epidemiology and determine the role of previous MMR immunisation on a large cohort of exposed people.
Results from oral fluid antibody testing and self-collected buccal swabs tested by real-time PCR were reconciled and analysed to determine level of agreement and to calculate MMR vaccine efficacy during the outbreak.
During the outbreak 1435 notifications of measles were received from across Wales. Samples were received from 70% of notified cases with a positivity rate of 56% within the outbreak compared to 15% for the rest of Wales. Measles RNA was detected in 53 cases with previous history of MMR immunisation, but viral loads were lower than those detected in unimmunised cases. The molecular epidemiology showed at least two distinct D8 strains of measles virus were introduced into Wales along with a separate introduction of a B3 strain outside the outbreak area.
Molecular testing of all notified measles cases offers the most rapid way of confirming the introduction of measles into a population potentially before secondary transmission has already occurred. The outbreak data confirms the protective effect of the MMR vaccine with vaccine efficacy calculated at 96% for one dose and 99% for two doses supporting the WHO recommendations for a two dose MMR immunisation schedule.
我们描述了对2012 - 2013年发生在英国威尔士中部和西部的大规模麻疹疫情的实验室应对情况。
证明快速麻疹检测对大规模疫情管理的影响,展示复杂的分子流行病学,并确定既往麻疹、腮腺炎和风疹(MMR)免疫接种对大量暴露人群的作用。
对通过实时聚合酶链反应(PCR)检测的口腔液抗体检测结果和自行采集的颊拭子检测结果进行核对和分析,以确定一致性水平并计算疫情期间MMR疫苗的效力。
疫情期间,威尔士各地共收到1435例麻疹通报。70%的通报病例提供了样本,疫情期间阳性率为56%,而威尔士其他地区为15%。在53例有MMR免疫接种史的病例中检测到麻疹RNA,但病毒载量低于未接种疫苗的病例。分子流行病学显示,至少有两种不同的D8株麻疹病毒被引入威尔士,同时在疫情区域外单独引入了一株B3株。
对所有通报的麻疹病例进行分子检测是在二次传播可能已经发生之前确认麻疹传入人群的最快速方法。疫情数据证实了MMR疫苗的保护作用,计算得出一剂疫苗效力为96%,两剂为99%,支持世界卫生组织关于两剂MMR免疫接种计划的建议。